Similarly, anti-TNF therapies including etanercept, infliximab, and adalimumab are commonly used in the treatment of autoimmune diseases such as rheumatoid arthritis, Crohn’s disease, psoriatic arthritis, and psoriasis [75,76]. This evidence concerns the gene TNF and psoriatic arthritis.